Yesterday we did have some good news for cancer survivors which didn’t get any significant attention. Most of the media attention from yesterday’s congressional budget vote was focused on an amendment dealing with NSA surveillance, the House did actually vote on final passage on the FY14 Defense Appropriations bill which included funding for the Department [...]
According to a news from CNN a short time ago the FDA shut down 1,677 online pharmacies. It was reported that 58 people were arrested and that 41 million dollars worth of illegal, counterfeit drugs were seized from 100 different countries. According to The National Association of Boards of Pharmacy there are over 10,000 online [...]
The great news for for our brothers in Europe is that Xtandi (Enzalutamide) has been approved for use in the European Union (EU) for the treatment of men with metastatic castration-resistant prostate cancer whose disease has progressed on or after chemotherapy (docetaxel). Following the regulatory review process by the European Medicines Agency (EMA) and a [...]
I have often discussed the importance of the Prostate Cancer Research Program (PCRP), which is a part of the Department of Defense (DOD) Medical Research Program. The program is geared to delivering funding for prostate cancer research that is translational, or will be quickly interpreted in the clinic. Like all other government funding it very [...]
The news is in, and it is bad. It is as bad as many of us feared. The National Institute of Health (NIH) has announced that their across-the-board budget sequester cuts are going to equal 1.71 billion dollars. The NIH is responsible for the majority of cancer research performed in the United States. For the [...]